Extrawell Pharmaceutical Holdings Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was HKD 73.93 million compared to HKD 78.8 million a year ago. Net income was HKD 130.59 million compared to net loss of HKD 121.1 million a year ago. Basic earnings per share from continuing operations was HKD 0.0546 compared to basic loss per share from continuing operations of HKD 0.0507 a year ago. Diluted earnings per share from continuing operations was HKD 0.0436 compared to diluted loss per share from continuing operations of HKD 0.0507 a year ago.